Interestingly, the mTOR blocker everolimus can inhibit the Warburg effect by blocking the PI3K/Akt/mTOR signaling pathway, thereby reducing the sensitivity of pancreatic cancer cells to GEM (74). The gene discussed is AKT1; the disease is pancreatic neoplasm.